Shareholders &
Partners

Welcome to the Investors and Partners section of PROVIREX Genome Editing Therapies GmbH. We are a pioneering biotech company dedicated to the development of cutting-edge Advanced Therapy Medicinal Products (ATMPs) that have the potential to revolutionize the field of genome editing and combat life-threatening persistent virus infections.